Healthgen Biotech specializes in molecular pharmaceutical research and development. Its commission is to use a state-of-art technology, rice endosperm cell specific expression platform (Oryzᴴⁱᴱˣᵖ), having high capacity to express proteins or small peptides in the rice grain, to develop the plant-made pharmaceuticals (PMP). The PMP provides a new approach for production of biopharmaceuticals. 

We are committed to supplying green, safe, accessible and sufficient biopharmaceutical products to people worldwide and improving global public health. 

The pharmaceutical pipeline below is updated as of August 2026.